AlphaTON Capital Corp. (ALP) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.2x

Market Cap

$7.63M

MomentumView details →

1D Return

−14.43%

YTD Return

−83.32%

RSI (14)

26.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.2x

Market Cap

$7.63M

RSI (14)

26.7

MomentumView details →

1D Return

−14.43%

YTD Return

−83.32%

ProfitabilityView details →

Gross Margin

100.00%

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−600.69%

ROA (TTM)

−222.35%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+26.92%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

−$0.04

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

0.31x

Quick Ratio

0.31x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

97000.00

Net Income (TTM)

−43.42M

Op. CF (TTM)

−31.54M

Latest newsMore news →

No recent news for ALP.

Similar companies

ZyVersa Therapeutics, Inc.ZVSA Bolt Biotherapeutics, Inc.BOLT Acurx Pharmaceuticals, Inc.ACXP InMed Pharmaceuticals Inc.INM Creative Medical Technology Holdings, Inc.CELZ Curanex Pharmaceuticals Inc Common StockCURX Find similar companies →

Latest newsMore news →

No recent news for ALP.